Latest News
The One Health concept requires direct action. That is what the different experts at the Annual Scientific Meeting of the Netherlands Centre for One Health (NCOH) in Wageningen agreed upon. Which action should be taken, depends on the perspective and field of expertise. “Our future starts today, with every step we take”, said Tim van Hattum (WUR).
The ERC Advanced grant is awarded to Gilles van Wezel, Professor of Molecular Biotechnology of the Institute Biology Leiden (IBL) of Leiden University. With 2.5 million euro grant of the European Research Council, he will focus on unravelling the systems that control the production of antibiotics in the bacteria Streptomyces.
On 23 March 2022, Quinten Ducarmon was the first PhD candidate within the PhD research programme of the Netherlands Centre for One Health to graduate, and he did so with distinction (cum laude). In his research he aims to identify intestinal bacteria that may play a role in colonization resistance against potential pathogens and antibiotic-resistant microorganisms in the gastrointestinal tract.
NCOH Student Travel Grant
The NCOH awards a number of travel grants to PhD students of NCOH Partners selected to present their abstract at an international One Health-related academic conference.
On 7 October ‘To end human deaths by rabies in 2030’ was the topic of the NCOH webinar. Rabies kills one person every 9 minutes, with over half of them children. It is a zoonotic and viral disease which occurs in more than 150 countries.
Anna Mykytyn is developing new methods to study the way antibodies neutralize viruses to understand how viruses enter the body.
Iris Swart’s research focusses on llama-derived nanobodies – no, really. Specifically cross-reactive nanobodies, that target multiple viruses. They could be important to help make the world more pandemic-prepared.
Initially looking at a career in drug development, Remy Muts’ interest in fundamental research finally brought him to where he is now: researching the complement system to find a possible therapeutic application.
Our partners
